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Abstract
 
Base substitutions, deletions, and duplications are observed at the immunoglobulin locus in
DNA sequences involved in class switch recombination (CSR). These mutations are dependent
upon activation-induced cytidine deaminase (AID) and present all the characteristics of the
ones observed during V gene somatic hypermutation, implying that they could be generated by
the same mutational complex. It has been proposed, based on the V gene mutation pattern of
patients with the cancer-prone xeroderma pigmentosum variant (XP-V) syndrome who are
deficient in DNA polymerase 
 
 
 
 (pol 
 
 
 
), that this enzyme could be responsible for a large part
of the mutations occurring on A/T bases. Here we show, by analyzing switched memory B
cells from two XP-V patients, that pol 
 
  
 
is also an A/T mutator during CSR, in both the
switch region of tandem repeats as well as upstream of it, thus suggesting that the same error-
prone translesional polymerases are involved, together with AID, in both processes.
Key words: somatic mutation • pol 
 
 
 
 • translesional DNA polymerases • 
xeroderma pigmentosum variant syndrome
 
Introduction
 
Since the discovery of activation-induced cytidine deaminase
(AID) and of its central role in the initiation of the three
postrearrangement B cell diversification processes, somatic
hypermutation (SHM), class switch recombination (CSR),
and gene conversion, a major question is to unravel what
are the common and the specific partners involved in these
different pathways (1, 2). SHM implies the introduction
mainly of base substitutions, but also of deletions and dupli-
cations into V genes to generate an antigen receptor with
better affinity for the immunizing antigen. Translesional
DNA polymerases, which are able to bypass specific DNA
lesions in an error-free mode at the replication fork but are
highly error-prone when copying undamaged DNA, have
been suspected to be involved in an error-prone short
patch DNA synthesis taking place during SHM (3). It has
since been reported, based on a study of SHM in patients
with xeroderma pigmentosum variant (XP-V), a cancer-prone
disease corresponding to a deficiency in DNA polymerase
 
 
 
 (pol 
 
 
 
; 4), that this enzyme might be responsible for a
large part of the mutations occurring at A/T basepairs (5).
In CSR, the heavy chain 
 
  
 
constant region is switched
to downstream constant region genes that are responsible
for various effector functions once the antibody has bound
its cognate antigen. The heavy chain 
 
  
 
locus region that is
targeted for CSR, encompasses a large DNA region starting
downstream of the I
 
  
 
exon up to a region of repetitive
pentamer motifs constituting the core 
 
  
 
switch region (S
 
 
 
;
6). Base substitutions, deletions, and duplications have been
observed around switch junctions (7). More recently, muta-
tions that display many characteristics of SHM, that is, base
substitutions on RGYW hotspot motifs (with R for purine,
Y for pyrimidines, and W for A or T; 8), bias for transitions
and AID dependence have been described downstream of
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the I
 
  
 
exon, outside the switch core region (9, 10). Here
we show, by studying hypermutation at the heavy chain
locus in memory B cells of two XP-V patients, that pol 
 
  
 
is
involved in hypermutation taking place during SHM and
CSR as well, implying that the same mutational complex is
probably recruited during these two DNA transactions.
 
Materials and Methods
 
Characteristics of XP-V Patients and Preparation of Cell Samples.
 
Blood samples were obtained from four healthy donors (34, 37, 41,
and 50 yr old) and two French XP-V patients (55 and 56 yr old)
after informed consent. The two XP-V patients studied were diag-
nosed clinically and biologically. Patient 1 showed numerous skin
tumors since the age of 26. Patient 2 had her first malignant mela-
noma at 30 and numerous melanomas, basal cell carcinomas, and
squamous cell carcinomas since then. Their cultured fibroblasts ex-
hibit normal UV-C–induced unscheduled DNA synthesis and are
UV-C sensitive in the presence of caffeine, a hallmark of XP-V
cells (11). Heterozygous mutations of the 
 
POL H
 
 gene were found
for both of them: a stop codon at amino acid 303 and a 4-bp dele-
tion at amino acid 408 for patient 1, and a Gly to Arg amino acid
substitution at position 295 and a 2-bp deletion (1,727–1,728) at
amino acid 576 for patient 2. CD19
 
  
 
CD27
 
  
 
IgD
 
  
 
memory B cells
were purified by cell sorting as previously described (12) and DNA
was extracted using proteinase K digestion.
 
PCR and Sequence Analysis.
 
The J
 
H
 
4 intronic sequence was
amplified using an FR3 consensus primer CACGGCYGTG-
TATTACTGTGC and a primer upstream from J
 
H
 
5, AGGAC-
CCCAGGCAAGAAC (at 94
 
 
 
C for 45 s, 55
 
 
 
C for 1 min, and
72
 
 
 
C for 2 min for 40 cycles with Pfu polymerase; Stratagene).
The sequence upstream from the S
 
  
 
core was amplified using the
following primers: 5
 
 
 
-S
 
 
 
, GAATGATTCCATGCCAAAGC
and 3
 
 
 
-S
 
 
 
, AGCTGGATGGAGTTGTCATGGC (at 94
 
 
 
C for
45 s, 56
 
 
 
C for 1 min, and 72
 
 
 
C for 3 min for 35 cycles with Pfu
polymerase), and the S
 
 
 
–
 
 
 
 switch region (S
 
 
 
)
 
 
 
switch junctions
with S
 
 
 
-ext, GGGGACCTGCTCATTTTTATC and S
 
 
 
-ext,
CCCTCAGAACCCCTAAGAAC (at 94
 
 
 
C for 45 s, 60
 
 
 
C for 1
min, and 72
 
 
 
C for 3 min for 40 cycles using Pfu Turbo polymer-
ase). In this last case, multiple PCRs were performed on aliquots
of 2,000–5,000 cells, and PCR products below 1 kb were se-
lected for cloning. PCR products were cloned using the TOPO
TA cloning kit (Invitrogen) and sequences were determined on
an ABI prism 3100 Analyzer (Applera). All amplifications were
performed using Pfu polymerase with a number of cycles to keep
background mutations at a minimal level. Mutations induced
during amplification by polymerases devoid of proofreading show
an A/T over G/C bias that may confuse analysis, notably in the
case of switch junction mutations. Error rate of Pfu polymerase is
in our assay around 5 
 
  
 
10
 
 
 
5 
 
for 40 cycles of amplification.
 
Results and Discussion
 
DNA pol 
 
  
 
has been proposed as an A/T mutator of Ig
V genes (5). This was based on the analysis of the mutation
pattern of functional V
 
H
 
6 genes from three XP-V patients,
with characterized mutations of pol 
 
  
 
for two of them.
However, the question of the exact contribution of pol 
 
 
 
to hypermutation has been challenged by Dorner and
Lipsky (13). By studying one of these three patients by a
single cell PCR approach, designed at amplifying both
functional and nonfunctional V
 
H 
 
genes, they failed to ob-
served such a deficiency at A/T targeting and concluded
that it might be a bias introduced by the study of selected V
gene sequences (14).
To readdress this question, CD27
 
  
 
IgD
 
  
 
memory B cells
from two XP-V patients and from four normal individuals
were purified by cell sorting and mutations were analyzed
in three noncoding regions of the heavy chain locus: the
J
 
H
 
4 intron, the S
 
 
 
 core upstream region, and S
 
 
 
–S
 
 
 
switch junctions (Fig. 1).
The J
 
H
 
4 intron downstream from rearranged V
 
H 
 
genes
was amplified using a 5
 
  
 
FR3 primer consensus for all hu-
man V
 
H 
 
genes, and 283 bp starting at the border of J
 
H
 
4 in-
tron were sequenced. Only sequences corresponding to dif-
ferent V-D-J junctions were considered. The J
 
H
 
4 segment
was used in 50% of rearranged V
 
H 
 
genes; such an approach
allows a large sampling of unselected sequences (Fig. 2 a; ref-
erence 15). The mutation frequency was 2.0/100 bp for the
controls, and 1.5 for the XP-V patients (Table I). In both
groups, mutations bore the hallmark of somatic mutations:
prevalence of base substitutions (with 6–9% of total muta-
tions representing deletions or duplications), bias for transi-
tions (47–51% of all mutations), and targeting of RGYW
motifs (Table II). This targeting was calculated taking into
account mutations occurring at the G position of the hotspot
motif only (considered for both strands of DNA), as com-
pared with mutations at other G/C positions. Moreover,
normal controls showed a marked preference for mutations
at A over T positions. In accordance with Zeng et al. (5), we
observed a drastic reduction of mutations on A/T bases in
XP-V patients as compared with the controls (10.7 vs.
54.0%; Fig. 2 a), thus confirming the implication of pol 
 
 
 
.
The lower number of events on A/T bases also correlates
with a slight reduction in the total amount of mutations, ob-
viously only noticeable on such unselected targets.
To find out whether the mutations observed during
CSR and SHM were generated by the same mutational
Figure 1. Schematic representation
of the regions selected for mutation
analysis at the Ig heavy chain locus.
The configuration selected repre-
sents a VH gene rearranged to JH4
and switched to the  -constant region
( 1 or  2). Horizontal arrows above
the locus represent transcription ini-
tiation sites. Dotted lines between
arrows mark the DNA regions amplified and the bold line represents the DNA regions sequenced. E , heavy chain enhancer; L, leader; V, variable; D,
diversity; and J, joining coding elements; I , intronic leader exon; S  and S , core switch regions. 
Faili et al.
 
267
complex, we analyzed two regions of the heavy chain locus
that undergo hypermutation during CSR in memory B
cells of both groups: the region upstream of the S
 
  
 
core re-
gion and S
 
 
 
–S
 
  
 
junctions. AID-dependent mutagenesis of
the S
 
  
 
core upstream region has been shown to be induced
after in vitro induction of switch in mouse splenic B cells
(9, 10). Mutations in this region have also been detected in
human chronic lymphocytic leukemia (16).
A region of 900 bp upstream from the core repetitive
sequences of the S
 
  
 
region was amplified from controls
and XP-V patients, and the sequence of the 3
 
  
 
295 bp was
determined (16). A mutation frequency of 0.31/100 and
0.21/100 bp was found for the controls and the XP-V in-
dividuals, respectively, i.e., a value six- to sevenfold lower
than for the J
 
H
 
4 intron (Table I). It should be noted that
both alleles are scored in this assay and that the precise
fraction of nonfunctional alleles that undergo isotype
switch in memory B cells in vivo is not known. The pat-
tern of mutation was very similar to the one observed at
the VDJ locus considering the ratio of base substitutions
over deletions and duplications, the bias for transitions and
for A over T mutations (although somewhat reduced), and
the targeting to G/C bases of the RGYW (WRCY) mo-
tifs (Table II and Fig. 2 b). This similarity extends to the
selective deficiency of mutations at A and T positions ob-
served for the two XP-V patients in this genomic se-
Figure 2. Mutation pattern of JH4 intronic sequences
and S  core upstream regions in normal controls and
XP-V patients. (a) Distribution and nucleotide substi-
tution preference of mutations in JH4 intronic sequences.
The distribution of mutations is represented along the
283 bp of intronic JH4 sequence, with the proportion
of mutated clones in ordinates. Mutations from normal
controls are represented above the nucleotide position,
and those from XP-V patients are below. Nucleotide
substitution preferences are corrected for base com-
position. A, 18.0%; G, 31.1%; C, 32.2%; T, 18.7%.
(b) Distribution and nucleotide substitution preference
of mutations in S  core upstream sequences. Mutations
obtained for normal controls are represented above the
295 nucleotides of the S  core upstream sequence, and
those from XP-V patients are below. The G position
of the RGYW motif (and the C position of the com-
plementary WRCY motif on the other strand) is high-
lighted in gray. Nucleotide substitution preferences are
corrected for base composition. A, 28.5%; G, 28.8%;
C: 20.0%; T, 22.7%.
 
Table I.
 
Somatic Mutations in J
 
H
 
4 Intronic Sequences and S
 
  
 
Core Upstream Sequences from Normal Individuals and XP-V Patients
 
J
 
H
 
4 intronic sequence (283 bp) S
 
  
 
core upstream sequence (295 bp)
Control XP-V Control XP-V
Number of sequences 73 41 199 101
Total length sequenced (bp) 20,659 11,603 58,705 29,795
Unmutated sequences (percent) 2.7 2.4 54 59
Total number of mutations 414 168 180 63
(Number of deletions and duplications) (23) (15) (11) (8)
Mutations range per mutated sequence 1–25 1–19 1–11 1–5
Mutation frequency (per 100 bp) 2.0 1.5 0.31 0.21 
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quence as well (10.2% in XP-V patients compared with
47.4% in controls).
S
 
 
 
-S
 
  
 
switch junctions from either S 1 or S 2 loci
were amplified and PCR products below 1 kb were iso-
lated and sequenced. An average of 170 bp on the S  side
and 211 bp on the S 1 or S 2 side were determined for
control sequences, and 200 bp on the S  side and 317 bp
on the S  side were determined for the XP-V individuals
(Table III). A similar mutation frequency was observed for
both control and XP-V patients (0.43/100 and 0.50/100
bp, respectively; Table III). Mutations were mainly base
substitutions (deletions over 25 bp were not included and
considered as an internal switch event), with a bias for tran-
sitions (51.8 and 59.4 for controls and XP-V patients, re-
spectively; Fig. 3). The switch core region, which is made
of pentamer repeats, differs from other regions of the heavy
chain locus that are targeted for mutations under two as-
pects: first an extreme incidence of G/C bases within
RGYW hotspots, as the switch repeat motif at both S  and
S  loci GAGCTGGGCT includes three G/C bases out of
seven in such a context. Accordingly, 79–89% of all G/C
mutations are targeted to such hotspot positions. The sec-
ond specific feature is a high G/C content with a marked
G/C imbalance (40% G and 20% C in the reference se-
quence of the nontranscribed strand). Therefore, mutations
have been tabulated in two different ways: as raw propor-
tions, thus reflecting their real occurrence in the sequence
studied, and also after correction for base composition, re-
flecting then their mechanistic occurrence (Fig. 3). The
G/C targeting was higher than in the other regions of the
heavy chain locus for the controls, even after correction for
the base composition. Nevertheless, there was still a clear
diminution of mutations on A/T bp in the XP-V patients
with a threefold reduction compared with control values
(6.6 vs. 19.6%), a figure similar to the one found for either
the JH4 intron or the S  core upstream region. The mod-
erate intervention of pol   can probably also explain why
the frequency of mutations is approximately similar for the
two groups of individuals in this region. We also observed
that cytosines were twice as often targeted than guanines
Table II. Somatic Mutations at G/C Positions of RGYW (or WRCY) Motifsa
JH4 intronic sequences
(283 bp)
S  core upstream sequences
(295 bp)
S  core junctional sequencesb 
(250 bp)
G/C within RGYW motifs 14% 19% 35%
Per total G/C bases (22/157) (27/144) (50/142)
G/C mutated within RGYW motifs 36% 49% 79%
Per total G/C bases in sequences
from normal controls (89/246) (45/86) (57/72)
G/C mutated within RGYW motifs 31% 57% 89%
Per total mutated G/C bases in
sequences from XP-V patients (45/147) (28/49) (40/45)
aOnly the underlined G or C base within the motif is considered.
bSequences listed in Fig. 3 are tabulated.
Figure 3. Mutation pattern of S –
S   junctions in normal controls and
XP-V patients. (a) Mutation distribu-
tion along the first 250 bp of the S 
region in S –S  junctions. Mutations
collected from normal controls are
listed above the reference sequence,
and mutations from XP-V patients are
below. The G position of the RGYW
motif (and the C position of the com-
plementary WRCY motif on the other
strand) is highlighted in gray. (b) Nucle-
otide substitution preference of muta-
tions in S –S   junctions. Mutations
collected on both S  and S  regions
are tabulated, first as raw proportions
and then after correction for base com-
position, taking into account the base
composition of the average region se-
quenced in each case. S  controls: 170 bp, 25.9% A, 30.0% G, 22.3% C, and 21.8% T; S  controls: 211 bp, 12.6% A, 47.6% G, 18.6% C, and 21.2% T;
S -XP-V: 200 bp, 25.5% A, 31% G, 22% C, and 21.5% T; S -XP-V: 350 bp, 12.9% A, 46.1% G, 19.6% C, and 21.4% T.Faili et al. 269
after correction for base composition, but that the absolute
number of Cs and Gs mutated was the same. The I  sterile
transcript has been shown to form an R loop with its tem-
plate strand (17), which would favor the attack of the single
stranded nontranscribed strand of DNA by AID according
to its in vitro substrate preference (18–22). Assuming that
most of the G mutations scored are due to an AID-medi-
ated attack of cytosines on the template strand, it is tempt-
ing to propose that the lower accessibility to AID of this
strand that forms a DNA–RNA hybrid is compensated by
its C richness, whereas the C poorness of the accessible
strand is compensated by its preferential targeting. Both
factors, AID substrate preference and evolution of target se-
quences, would ensure approximately the same amount of
AID-mediated deamination on each strand, thus allowing
for efficient generation of double stranded breaks, necessary
for the switch recombination process (23).
In conclusion, we would like to propose that the muta-
tions observed during CSR most probably involve the
SHM mutasome. The pattern of mutation is clearly more
G/C targeted in the S  core region. This G/C targeting
might be explained by the G/C richness within pentameric
hotspots in this region and the unique accessibility pro-
vided by the R loop structure, so that less nuclease diges-
tion, and/or less error-prone short patch DNA synthesis
would be required to generate adjacent cleavage sites, i.e.,
double stranded breaks that can be engaged into a success-
ful switch recombination event. A similar conclusion was
drawn from a study on the role of MSH2 during CSR (24)
showing that this molecule is more specifically required for
switching occurring in the S  upstream region. In this re-
gion, the lower density of hotspots, as compared with the
S  core, may require more processing of the DNA ends to
render them suitable for recombination, a processing that
would rely on the strand displacement activity of MSH2.
This work also brings the confirmation that the transle-
sion DNA synthesis (TLS) polymerase pol   is an A/T mu-
tator. Nevertheless, there are still mutations on A/T bases in
both SHM and CSR. Therefore, it is probable that other
TLS polymerases, such as pol   that interacts with pol   at rep-
lication foci, could be involved in both processes (25). Ac-
cordingly, in a human Burkitt’s B cell line inducible for SHM
and whose pattern of mutations is strongly G/C biased, in-
duction of SHM was shown to be dependent on pol   (26,
27). This result remains controversial because it was recently
reported that 129/SvJ mice that lack a functional pol   did not
show any significant change in the frequency and pattern of Ig
mutations (28). To what extent the human in vitro and mice
in vivo systems differ and to what extent TLS polymerases
may compensate for each other remains to be explored.
The rationale for using error-prone polymerases during
CSR is not clearly perceptible. Here we propose that these
enzymes participate in an AID-triggered, short patch DNA
synthesis ensuring the efficient fill-in of staggered double
strand breaks. However, we cannot exclude that the muta-
tions observed may represent the bystander recruitment of
AID partners involved in the mutagenesis of Ig V genes,
and that the involvement of TLS polymerases as cofactors
of the nonhomologous end joining process might be dis-
pensable. An in vitro system that would enable to assess the
impact of these polymerases on the strict efficiency of
switching may help resolve this issue.
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